Objective. To test the hypothesis that at-risk drinking is associated with a smaller probability of prior HIV testing and access to antiretroviral treatment (ART) among injection drug users (IDUs) entering treatment for drug abuse. Methods. HIV infected IDUs (N ¼ 643) entering detoxification or methadone maintenance treatment in New York City between 1997 and 2002 comprised the participants. Multivariate logistic regression was used to assess whether receiving ART was associated with at-risk drinking. Results. A significantly smaller proportion of at-risk drinkers, compared to nondrinkers and moderate drinkers, reported receiving ART.
Introduction
Advances in HIV treatment have dramatically increased survival rate of HIV-infected patients. [1] [2] [3] Treatments may also reduce the transmission of HIV due to sexual exposure. For example, 1 study 4 followed heterosexual couples in stable relationships in which the only risk factor for the uninfected nonindex partner was sexual contact with the index case. All nonindex partners of HIV-infected individuals who had been treated with highly active antiretroviral therapy (HAART) remained uninfected, whereas 9% of nonindex partners of those without treatment became infected with HIV.
In spite of these benefits, not all HIV-infected patients may be receiving optimal HIV treatment. Antiretroviral therapy (ART) is challenging, may be complicated by other considerations, and requires compliance with burdensome regimens. 5 Race/ ethnicity, gender, and age may be associated with reduced access to ART, 6, 7 and active drug use may be related to reduced access and adherence. 8, 7 Injection drug users (IDUs), in particular, have been found to receive less ART and derive less benefit from ART when they do receive it. 9 Some of the disparities in ART among IDUs may be explained by active drug use, 10 and being in drug abuse treatment has been linked to better access and adherence. 11, 12 Yet, drug abuse treatment itself may provide additional challenges to ART. Injection drug users, in treatment for their drug abuse, who are maintained on methadone may require modifications to their ART regimens as a result of drug interaction between methadone and ART. 13, 14 Alcohol use may also play a role in access to ART and adherence among IDUs. An earlier version of the US Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 15 states active drug and alcohol use as predictors of inadequate adherence. A survey of a random sample of infectious disease physicians found that most physicians follow these guidelines and report that heavy alcohol use and injection drug use negatively influence their decision to prescribe HAART. 16 Another survey was conducted among HIV-infected patients attending an AIDS service clinic to assess the independent effect of alcohol and the combined effect of alcohol with other drugs on using and adhering to ART, as well as on viral suppression. 17 Results indicated that hazardous drinkers were less likely to use and adhere to ART than nondrinkers and showed less viral suppression.
This report examines data from an ongoing study of HIV risk behaviors conducted among IDUs entering detoxification or methadone maintenance treatment in New York City between 1997 and 2002. The aim of this article is to examine the association of at-risk drinking with HIV testing and receiving ART among IDUs.
Methods

Design and Recruitment
The data reported here are part of an ongoing series of studies of HIV infection and risk behaviors among drug users entering the Methadone Maintenance Program (MMTP) and the Detoxification Treatment Program of the Beth Israel Medical Center. Each year the programs admit a large number of injecting and noninjecting drug users (up to 7000). For this report, we included only HIV-seropositive IDUs admitted to the programs from 1997 to 2002. We defined IDUs as active drug users (ie, drug use in the previous 6 months) who had ever injected drugs.
Newly admitted Detoxification and MMTP clients who were at least 18 years of age, had used drugs within the 6 months prior to the interview, and had not participated in the study in the previous 12 months were eligible to participate. To recruit participants from the Detoxification program, the interviewer visited the general admission wards of the program and identified patients admitted within the previous 3 days from the intake records. All eligible patients present on the ward were solicited for participation in the study. Some patients were unavailable for participation due to appointments scheduled by hospital staff. Among patients approached and eligible, willingness to participate was more than 95%. Almost half those who refused were feeling too sick from drug withdrawal.
To recruit participants from the MMTP, the interviewer reviewed the list of IDUs scheduled for intake at the central intake facility. Each applicant to the Beth Israel MMTP system was required to attend intake sessions at the central facility before being assigned to a clinic convenient to his/her home. The program intake process included numerous appointments with MMTP staff that stretched over several hours, interspersed with long waiting periods. Throughout the day, the interviewer approached all listed IDUs in the waiting room to ask if they would participate in the study. Over 80% of eligible MMTP patients approached agreed to participate in the study. Primary reasons for study participation refusal included having other commitments or fatigue due to the time-consuming intake process.
After providing informed consent, study recruits were individually interviewed in private by a trained interviewer. A structured questionnaire was administered as part of the interview. Pretest counseling was provided and a separate informed consent for HIV testing was obtained. HIV testing was conducted using replicate enzyme-linked immunosorbent assay with Western blot confirmation at the New York City Department of Health Laboratory.
Measures
The questionnaire included items assessing sociodemographics, drug and alcohol use, sexual activity and risk behaviors, prior HIV testing, and HIV treatment. Drug and alcohol measures, as well as sexual activity and risk behaviors, reflected behaviors occurring during the 6-month period prior to interview. Alcohol use was assessed as number of drinks in a typical week in the 6-month period and was analyzed as an ordinal variable. According to the US National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines for physicians, men who drink more than 4 standard drinks in a day (or more than 14 per week) and women who drink more than 2 in a day (or more than 7 drinks per week) are at increased risk for alcohol-related problems. 18, 19 We used the above criteria to classify males who had more than 14 drinks and women who had more than 7 drinks per week as at-risk drinkers. Those who had no drinks in a typical week were classified as nondrinkers. The remaining respondents were grouped as moderate drinkers.
The frequency of sexual activity and unprotected sex in the prior 6 months were also measured. In addition, we asked about the sex partners of the IDUs, including sex partners' disclosures about their drug injection and HIV seropositivity.
Self-reported prior HIV testing and treatment were assessed as dichotomous variables. Additional items probed the time and place of prior HIV testing, type of HIV treatment, and adherence to the medication.
Statistical Analyses
We used the chi-square test to assess any differences in the distribution of sociodemographic variables across recruitment sites. To assess the relationship of reported previous HIV testing and ART with the explanatory variables, we first used univariate logistic analyses. The main explanatory variable of interest was the level of alcohol use (ie, at-risk drinking, moderate drinking, and nondrinking). Because previous research has associated ART with gender, age, race/ethnicity, and current injection drug use, we also included these variables. Current injection drug use was defined as injecting within the 6 months prior to the interview. In addition, we included treatment program (ie, MMTP and detoxification) to test whether any difference between the programs existed. Next, we conducted multivariate analyses. Besides the level of alcohol use, covariates that had a significance level of P < .15 in the univariate analyses were included in the multivariate model. All demographic variables (ie, age, gender, race/ethnicity) were also entered into the multivariate model, regardless of level of significance, to adjust for their effect and to obtain adjusted odds ratios (AOR) and 95% confidence intervals (95% CI). Interactions of each of the covariates with level of alcohol use were also examined to detect any modification of the relationship between level of alcohol use and reported prior HIV testing and ART by 1 or more of the covariates. Backward elimination was used to exclude, in a step-wise manner, nonsignificant effects from the multivariate model. All analyses were carried out using SAS software, version 9. 20
Results
Sample Characteristics
A total of 643 IDUs were included. Detoxification program recruits comprised 55% of the sample. Table 1 presents demographic and alcohol and drug use characteristics by the recruitment site. Gender, race/ethnicity, and proportions of current injectors, daily injectors, and heroin injectors did not differ significantly by recruitment site.
Detoxification recruits (40 years of age) were slightly younger than MMTP recruits (41 years of age) and included a greater proportion of at-risk drinkers and crack cocaine users.
HIV Testing and ART
Previous HIV testing was reported by 84% of IDUs. Previous HIV-positive results were reported by 52% of IDUs. Overall, less than half of the IDUs who reported previous HIV seropositive results claimed they were receiving ART in the 6 months period prior to the interview. Because previous research has indicated that ART may reduce transmission of HIV due to sexual exposure, 4 (Castilla, Barrio, et al, 1999 #4560) we were also interested in assessing the risk to sex partners of IDUs who reported to be HIVseropositive but were not receiving ART. Among IDUs who reported they were HIV seropositive and had noninjecting, HIV-seronegative sex partners, the majority (55%) claimed they were not receiving ART. A substantial proportion (36%) of these IDUs reported engaging in unprotected sex with their partners. Table 2 presents the proportions who reported previous HIV testing and receiving ART by the level of alcohol use. Proportions engaging in unprotected sex are also shown for IDUs not receiving ART, but reporting HIV seropositivity and having noninjecting, seronegative sex partners. HIV testing did not significantly differ across levels of alcohol use. A significantly smaller proportion of at-risk drinkers, compared to moderate drinkers and nondrinkers, reported receiving ART in the 6-months period prior to the interview. Among IDUs not receiving ART, but reporting HIV seropositivity and noninjecting, HIV-seronegative sex partners, a significantly greater proportion of at-risk drinkers (compared to nondrinkers and moderate drinkers) engaged in unprotected sex.
We conducted univariate and multivariate logistic analyses to examine the associations of reported HIV testing and ART with recruitment site, level of alcohol use, and theoretically important covariates, including gender, race/ethnicity, age, crack cocaine use, and year of interview. In univariate analyses, the likelihood of HIV testing was not significantly different across levels of alcohol and drug use. Only gender was significantly associated with different likelihoods of HIV testing. Men were less likely than women to report previous HIV testing. Table 3 shows the odds ratios for reporting ART associated with demographic and alcohol and drug use characteristics in univariate logistic analyses. Reporting ART in the previous 6-months period was associated with levels of alcohol use and with crack cocaine use. Atrisk drinkers were less likely, compared to nondrinkers, to report receiving ART. Crack cocaine users were also less likely, compared to nonusers, to report receiving ART.
Multivariate logistic analysis was only conducted for reporting ART, because in univariate analyses neither alcohol nor drug use were associated with previous HIV testing. Multivariate models for reported ART were fit by including the effects for level of alcohol use, recruitment site, demographic variables (ie, gender, age, race/ethnicity), crack cocaine use, and the interaction of level of alcohol use with each of the covariates. Table 4 displays the odds ratios of reporting ART associated with demographic and alcohol and drug use characteristics of the IDUs reporting previous HIV seropositivity. We observed a significant interaction between level of alcohol use and crack cocaine use for reporting ART. At-risk drinkers who used crack cocaine had a decreased likelihood of reporting ART, compared to nondrinkers who did not use cocaine. 
Discussion
Our results indicate that among IDUs entering treatment for drug abuse, at-risk drinkers who use crack cocaine, and daily injectors are more likely to report a lower rate of ART. To our knowledge, no previous study has reported these findings in IDUs. However, these results are consistent with findings of other studies that have shown a negative association between alcohol and drug use and receiving ART. Further, among IDUs not receiving ART, but reporting HIV seropositivity and having noninjecting, HIV-seronegative sex partners, we observed a significantly greater proportion (52%) of at-risk drinkers engaged in unprotected sex (compared to an average of 26% among others). The latter finding suggests that the noninjecting, HIV-seronegative sex partners of at-risk drinking IDUs are at increased risk for HIV transmission. These findings have several important implications. First, drug abuse treatment programs might improve access to ART among IDUs by screening for alcohol use and addressing at-risk drinking. Engaging in substance use treatment services has been reported to be associated with increased likelihood of receiving ART. 11, 12 However, for at-risk drinking IDUs, treatment for drug abuse without addressing alcohol use might not be sufficient for increasing the likelihood of receiving ART.
Second, effective HIV prevention among IDUs and their sex partners seems to require an even stronger emphasis on preventing HIV sexual risk behaviors. HIV sexual risk behaviors are clearly prevalent among IDUs who report they are HIV seropositive and have noninjecting, HIV-seronegative sex partners. For the latter, the predominant risk for contracting HIV would come from the IDUs who are their sex partners.
Finally, the interaction of crack cocaine use and at-risk drinking suggests a unique profile among IDUs. Identifying distinctive characteristics of these IDUs would likely improve HIV prevention and treatment further and requires special attention.
Our results are based on cross-sectional studies, whose limitations prevent us from inferring a causal relationship between at-risk drinking and ART. However, these results indicate an opportunity for improving access to ART among IDUs entering treatment for drug abuse and, indirectly, for reducing HIV transmission among sex partners of IDUs.
